Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

337 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Response to Vermorken et al--curcumin and free light chains.
Golombick T, Diamond T, Manoharan A, Ramakrishna R. Golombick T, et al. Among authors: diamond t. Am J Hematol. 2012 Oct;87(10):E80-1. doi: 10.1002/ajh.23294. Epub 2012 Jul 27. Am J Hematol. 2012. PMID: 22847387 Free article. No abstract available.
B-Cell Disorders and Curcumin.
Golombick T, Diamond TH, Manoharan A, Ramakrishna R. Golombick T, et al. Among authors: diamond th. Integr Cancer Ther. 2017 Sep;16(3):255-257. doi: 10.1177/1534735415622013. Epub 2015 Dec 16. Integr Cancer Ther. 2017. PMID: 26674787 Free PMC article.
Addition of Rice Bran Arabinoxylan to Curcumin Therapy May Be of Benefit to Patients With Early-Stage B-Cell Lymphoid Malignancies (Monoclonal Gammopathy of Undetermined Significance, Smoldering Multiple Myeloma, or Stage 0/1 Chronic Lymphocytic Leukemia): A Preliminary Clinical Study.
Golombick T, Diamond TH, Manoharan A, Ramakrishna R. Golombick T, et al. Among authors: diamond th. Integr Cancer Ther. 2016 Jun;15(2):183-9. doi: 10.1177/1534735416635742. Epub 2016 May 6. Integr Cancer Ther. 2016. PMID: 27154182 Free PMC article.
The potential role of curcumin in patients with monoclonal gammopathy of undefined significance--its effect on paraproteinemia and the urinary N-telopeptide of type I collagen bone turnover marker.
Golombick T, Diamond TH, Badmaev V, Manoharan A, Ramakrishna R. Golombick T, et al. Among authors: diamond th. Clin Cancer Res. 2009 Sep 15;15(18):5917-22. doi: 10.1158/1078-0432.CCR-08-2217. Epub 2009 Sep 8. Clin Cancer Res. 2009. PMID: 19737963 Clinical Trial.
337 results